Skip to content
Parker Institute for Cancer Immunotherapy
Search Close

The University of Pennsylvania

The University of Pennsylvania is a global leader in CAR-T cell therapy and in training immune cells to attack cancer cells

University of Pennsylvania drives new discoveries in cancer immunotherapy research on an international scale, and pioneered the first FDA-approved CAR-T cell therapy. Penn’s award-winning doctors and scientists focus on training immune cells to recognize and hunt cancer cells. PICI at Penn extends this work and supports laboratory studies and clinical trials, recruitment of talented new faculty and opportunities for early-career investigators who will train at Penn.

Carl June, MD | Director
E. John Wherry, PhD | Co-Director